GILEAD SCIENCES, INC. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, GILEAD SCIENCES, INC. held in its portfolio 6 assets valued at $1,935,507,854 (i.e. $1.94B).

The most valuable assets in the portfolio included: ARCUS BIOSCIENCES INC ($748.85M), GALAPAGOS NV ($550.62M), and ARCELLX INC ($438.20M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in GILEAD SCIENCES, INC. Portfolio

ARCUS BIOSCIENCES INC

GALAPAGOS NV

ARCELLX INC

ASSEMBLY BIOSCIENCES INC

KYVERNA THERAPEUTICS INC

XILIO THERAPEUTICS INC

GILEAD SCIENCES, INC. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ARCUS BIOSCIENCES INC	31424760	748852031	COM
GALAPAGOS NV	16707477	550616290	SPON ADR
ARCELLX INC	6720803	438196356	COMMON STOCK
ASSEMBLY BIOSCIENCES INC	4505391	153228348	COM NEW
KYVERNA THERAPEUTICS INC	4126119	38785519	COM
XILIO THERAPEUTICS INC	9105451	5829310	COM